12-month visual and safety outcomes of the ELIOS procedure with cataract surgery in primary open-angle glaucoma

PURPOSE: To characterize early safety and visual outcomes through 12 months following combined phacoemulsification and ELIOS excimer laser trabeculostomy procedure in patients with mild-to-moderate primary open-angle glaucoma (POAG). SETTING: Conducted at 20 US sites. DESIGN: Prospective, multicenter, non-randomized clinical trial (NCT04899063). METHODS: Adults aged ≥45 years with cataract and mild-to-moderate POAG underwent phacoemulsification with intraocular lens implantation followed immediately by the ELIOS procedure. Corrected distance visual acuity (CDVA), pachymetry, endothelial cell density (ECD), visual field measurements, and adverse events (AEs) were reported up to 12 months. RESULTS: A total of 318 patients underwent the procedure; mean±SD age was 70.3±7.3 years, 172 (54.1%) were female, and 263 (82.7%) were White. Five intraoperative AEs were reported during cataract procedure and none during ELIOS procedure. Visual recovery was rapid and sustained: at month 12, all patients achieved CDVA 20/40 or better; CDVA was <1 line of baseline in 28.0% of patients and improved by ≥1 line in 214 (69.8%), and no losses ≥2 lines. Corneal edema occurred predominantly early and resolved without sequelae. ECD loss occurred early then stabilized; median change and median percent change in ECD at month 12 were -237.0 cells/mm2 and -9.10%, respectively. Through 12 months, 73 postoperative ocular AEs were reported in 17.3% of patients; the most common AEs were anterior chamber cell/flare requiring increased or reinitiated steroid therapy (5.7%), and worsening of visual field mean deviation by ≥2.5 dB from baseline (4.4%). CONCLUSIONS: Combined phacoemulsification-ELIOS was associated with a safety profile consistent with published outcomes following phacoemulsification alone, with predominantly early, self-limited postoperative events.

Authors

Institutions

Publication Details

Journal
Journal of Cataract & Refractive Surgery
Published
2026-11-13
DOI
https://doi.org/10.1097/j.jcrs.0000000000002102
Primary Topic
Glaucoma and retinal disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

12-month visual and safety outcomes of the ELIOS procedure with cataract surgery in primary open-angle glaucoma

Navaneet S.C. Borisuth, George R. Reiss, Rupali S. Nangia, Steven R. Sarkisian et al.
4 links
Journal of Cataract & Refractive Surgery
Glaucoma and retinal disorders
article

12-month visual and safety outcomes of the ELIOS procedure with cataract surgery in primary open-angle glaucoma

Navaneet S.C. Borisuth, George R. Reiss, Rupali S. Nangia, Steven R. Sarkisian, Cathleen M. McCabe, Kelly Swaim, Yi-Jing Duh, Lalit Pukhrambam Singh, Iqbal Ike K. Ahmed, Mark Gallardo, Mohamed Yassine, Andy Lee, Hsin Yi Ling, on behalf of the ELTGTS Study Investigators
article en

Abstract

PURPOSE: To characterize early safety and visual outcomes through 12 months following combined phacoemulsification and ELIOS excimer laser trabeculostomy procedure in patients with mild-to-moderate primary open-angle glaucoma (POAG). SETTING: Conducted at 20 US sites. DESIGN: Prospective, multicenter, non-randomized clinical trial (NCT04899063). METHODS: Adults aged ≥45 years with cataract and mild-to-moderate POAG underwent phacoemulsification with intraocular lens implantation followed immediately by the ELIOS procedure. Corrected distance visual acuity (CDVA), pachymetry, endothelial cell density (ECD), visual field measurements, and adverse events (AEs) were reported up to 12 months. RESULTS: A total of 318 patients underwent the procedure; mean±SD age was 70.3±7.3 years, 172 (54.1%) were female, and 263 (82.7%) were White. Five intraoperative AEs were reported during cataract procedure and none during ELIOS procedure. Visual recovery was rapid and sustained: at month 12, all patients achieved CDVA 20/40 or better; CDVA was <1 line of baseline in 28.0% of patients and improved by ≥1 line in 214 (69.8%), and no losses ≥2 lines. Corneal edema occurred predominantly early and resolved without sequelae. ECD loss occurred early then stabilized; median change and median percent change in ECD at month 12 were -237.0 cells/mm2 and -9.10%, respectively. Through 12 months, 73 postoperative ocular AEs were reported in 17.3% of patients; the most common AEs were anterior chamber cell/flare requiring increased or reinitiated steroid therapy (5.7%), and worsening of visual field mean deviation by ≥2.5 dB from baseline (4.4%). CONCLUSIONS: Combined phacoemulsification-ELIOS was associated with a safety profile consistent with published outcomes following phacoemulsification alone, with predominantly early, self-limited postoperative events.

Journal of Cataract & Refractive Surgery
Prism Eye Institute (CA), Bausch + Lomb (United States) (US)
Good health and well-being
Glaucoma and retinal disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon